The FTC believes that the PBMs participated in unjust competition and practices, incentivizing manufacturers to increase insulin list prices. “Express Scripts intends to vigorously defend itself to ...

in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the FTC published a ...

While liberals have held their tongues as Kamala Harris tacked to the center, they're preparing for a major battle over the ...

The agency said they created a "perverse drug rebate system" that artificially inflates the price of insulin. Each company ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

The three firms—which the FTC says manages about 80% of prescriptions in the U.S.—have created a “perverse” drug rebate system that has “artificially inflated” insulin’s price ...

Pharmacy benefits managers have a tremendous impact on medication coverage. In my last article, which was devoted to the causes of dramatically rising prescription drug costs and potential ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Ohioans must recognize the threat that vertically-integrated insurance conglomerates pose to our health and pocketbooks.